title: Late-onset panhypopituitarism in a 72-year-old male patient treated with ipilimumab for metastatic melanoma: a case report.
authors.affiliation: Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Vancieri
authors.affiliation: Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bellia
authors.affiliation: Division of Endocrinology and Diabetology, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. d.lauro@med.uniroma2.it.
authors.forename: D
authors.initials: D
authors.lastname: Lauro
mesh_terms: D017668:Age of Onset; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D007018:Hypopituitarism / Q000139:chemically induced* / Q000175:diagnosis*; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab